Press "Enter" to skip to content

New patent for Pierre Fabre drug HEMANGEOL

0
Copyright © DrugPatentWatch. Originally published at New patent for Pierre Fabre drug HEMANGEOL

Annual Drug Patent Expirations for HEMANGEOL
Annual Drug Patent Expirations for HEMANGEOL

Hemangeol is a drug marketed by Pierre Fabre Derma and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has thirty-eight patent family members in thirty countries.

The generic ingredient in HEMANGEOL is propranolol hydrochloride. One supplier is listed for this compound. Additional details are available on the propranolol hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Pierre Fabre drug HEMANGEOL
    Do NOT follow this link or you will be banned from the site!